OMX Stockholm 30
2.670,54
PKT
+8,22
PKT
+0,31
%
Werbung
Analysen zu OMX Stockholm 30-Werten
Datum | Rating | Analyst | |
---|---|---|---|
08.04.22 | Hennes Mauritz (H M, H&M) Underperform | Credit Suisse Group | |
07.04.22 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
07.04.22 | Volvo (B) Neutral | JP Morgan Chase & Co. | |
06.04.22 | AstraZeneca Buy | Deutsche Bank AG | |
06.04.22 | ABB (Asea Brown Boveri) Outperform | Bernstein Research | |
05.04.22 | ABB (Asea Brown Boveri) Buy | UBS AG | |
05.04.22 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
05.04.22 | Hennes Mauritz (H M, H&M) Hold | Deutsche Bank AG | |
05.04.22 | Volvo (B) Buy | Jefferies & Company Inc. | |
04.04.22 | ABB (Asea Brown Boveri) Equal Weight | Barclays Capital | |
04.04.22 | ABB (Asea Brown Boveri) Hold | Jefferies & Company Inc. | |
01.04.22 | Hennes Mauritz (H M, H&M) Hold | Deutsche Bank AG | |
01.04.22 | Hennes Mauritz (H M, H&M) Sell | Goldman Sachs Group Inc. | |
31.03.22 | Hennes Mauritz (H M, H&M) Neutral | JP Morgan Chase & Co. | |
31.03.22 | Hennes Mauritz (H M, H&M) Outperform | RBC Capital Markets | |
31.03.22 | Hennes Mauritz (H M, H&M) Overweight | Barclays Capital | |
31.03.22 | Hennes Mauritz (H M, H&M) Hold | Jefferies & Company Inc. | |
31.03.22 | Hennes Mauritz (H M, H&M) Outperform | RBC Capital Markets | |
31.03.22 | Hennes Mauritz (H M, H&M) Sell | Goldman Sachs Group Inc. | |
31.03.22 | Hennes Mauritz (H M, H&M) Buy | UBS AG | |
31.03.22 | Hennes Mauritz (H M, H&M) Neutral | JP Morgan Chase & Co. | |
30.03.22 | AstraZeneca Buy | Deutsche Bank AG | |
29.03.22 | ABB (Asea Brown Boveri) Neutral | JP Morgan Chase & Co. | |
25.03.22 | ABB (Asea Brown Boveri) Conviction Buy List | Goldman Sachs Group Inc. | |
25.03.22 | Volvo (B) Buy | Goldman Sachs Group Inc. | |
22.03.22 | AstraZeneca Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
21.03.22 | Hennes Mauritz (H M, H&M) Buy | UBS AG | |
21.03.22 | Hennes Mauritz (H M, H&M) Outperform | RBC Capital Markets | |
21.03.22 | Hennes Mauritz (H M, H&M) Neutral | JP Morgan Chase & Co. | |
18.03.22 | Hennes Mauritz (H M, H&M) Overweight | Barclays Capital | |
18.03.22 | AstraZeneca Buy | Deutsche Bank AG | |
16.03.22 | Hennes Mauritz (H M, H&M) Hold | Deutsche Bank AG | |
15.03.22 | Hennes Mauritz (H M, H&M) Overweight | JP Morgan Chase & Co. | |
15.03.22 | Hennes Mauritz (H M, H&M) Underperform | Credit Suisse Group | |
15.03.22 | AstraZeneca Buy | Deutsche Bank AG | |
15.03.22 | Hennes Mauritz (H M, H&M) Overweight | JP Morgan Chase & Co. | |
09.03.22 | ABB (Asea Brown Boveri) Outperform | Bernstein Research | |
09.03.22 | Hennes Mauritz (H M, H&M) Sell | Goldman Sachs Group Inc. | |
09.03.22 | Hennes Mauritz (H M, H&M) Underperform | Credit Suisse Group | |
08.03.22 | ABB (Asea Brown Boveri) Outperform | Bernstein Research |
* Die angezeigten Realtime Kurse sind indikativ und nicht die offiziellen Börsenkurse. Die Kursdaten können eventuell vom tatsächlichen Marktpreis abweichen.